ReviewAdvances in therapy2026
Isthmocele: from Detection to Treatment: A Narrative Review.
Review in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endometriosis-Associated Infertility in China: Epidemiological Trends, Future Projection, and Real-World Clinical Insights.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Isthmocele, also known as cesarean scar defect, is an increasingly recognized complication of cesarean delivery, often associated with abnormal uterine bleeding, pelvic pain, and secondary infertility. This narrative review aims to provide a comprehensive overview of the condition, including its pathogenesis, risk factors, diagnostic methods, and current treatment options. The most significant risk factor for isthmocele formation is the number of previous cesarean sections, although other contributing elements include surgical technique, uterine position, and individual wound-healing capacity. Transvaginal ultrasound is the first-line imaging modality, while magnetic resonance imaging may provide enhanced visualization in selected cases. Management depends on the severity of symptoms, residual myometrial thickness, and reproductive goals. Treatment options range from conservative medical therapy to surgical interventions via hysteroscopic, vaginal, or laparoscopic approaches. Surgical correction is particularly indicated in symptomatic women with reproductive desire and thin residual myometrium. The choice of technique should be individualized on the basis of the characteristics of the defect, the presence of coexisting pathologies, and surgical expertise. Preventive strategies focus on optimal cesarean technique, with emerging evidence supporting the importance of suture method and postoperative ultrasound monitoring. Despite increasing awareness, standardized guidelines for diagnosis and treatment are lacking. A tailored approach remains essential, considering both clinical and anatomical variables. This review summarizes the current knowledge on isthmocele and highlights the need for further research to establish evidence-based protocols for diagnosis, prevention, and treatment.
Indexed as
Identifiers
41379303What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.